首页> 外文OA文献 >Genetic Modulation of the Overexpression of Tailoring Genes eryK and eryG Leading to the Improvement of Erythromycin A Purity and Production in Saccharopolyspora erythraea Fermentation▿
【2h】

Genetic Modulation of the Overexpression of Tailoring Genes eryK and eryG Leading to the Improvement of Erythromycin A Purity and Production in Saccharopolyspora erythraea Fermentation▿

机译:量身定制基因eryK和eryG的过量表达的遗传调控,导致红多糖发酵过程中红霉素A纯度和产量的提高▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Erythromycin A (Er-A) is the most potent and clinically important member in the Er family produced by Saccharopolyspora erythraea. Er-B and Er-C, which are biologically much less active and cause greater side effects than Er-A, serve as the intermediates for Er-A biosynthesis and impurities in fermentation processes of many industrial strains. In this study, systematical modulation of the amounts of tailoring enzymes EryK (a P450 hydroxylase) and EryG (an S-adenosylmethionine-dependent O-methyltransferase) was carried out by genetic engineering in S. erythraea, including alterations of gene copy number ratio and organization and integrating the locus on the chromosome by homologous recombination. Introduction of additional eryK and eryG genes into S. erythraea showed significant impacts on their transcription levels and enhanced the biotransformation process from Er-D to Er-A with gene dose effects. At the eryK/eryG copy number ratio of 3:2 as well as their resultant transcript ratio of around 2.5:1 to 3.0:1, Er-B and Er-C were nearly completely eliminated and accordingly converted to Er-A, and the Er titer was improved by around 25% in the recombinant strain ZL1004 (genotype PermK*-K-K-G + PermE*-K + PermA*-G) and ZL1007 (genotype PermK*-K-G-K + PermE*-K + PermA*-G). This study may contribute to the continuous efforts toward further evaluation of the Er-producing system, with the aims of improving Er-A purity and production at the fermentation stage and lowering the production costs and environmental concerns in industry.
机译:红霉素A(Er-A)是由红糖酵母产生的Er家族中最有效和临床上最重要的成员。 Er-B和Er-C的生物学活性比Er-A低得多,并引起更大的副作用,在许多工业菌株的发酵过程中充当Er-A生物合成和杂质的中间体。在这项研究中,通过遗传工程在红霉菌中对调节酶EryK(一种P450羟化酶)和EryG(一种S-腺苷甲硫氨酸依赖性O-甲基转移酶)的量进行了系统的调节,包括基因拷贝数比和通过同源重组组织和整合染色体上的基因座。将额外的eryK和eryG基因引入到红色链霉菌中对它们的转录水平产生了显着影响,并通过基因剂量效应增强了从Er-D到Er-A的生物转化过程。在eryK / eryG拷贝数比为3:2以及它们的转录本比率为约2.5:1至3.0:1时,Er-B和Er-C几乎被完全消除,因此转化为Er-A,并且重组菌株ZL1004(基因型PermK * -KKG + PermE * -K + PermA * -G)和ZL1007(基因型PermK * -KGK + PermE * -K + PermA * -G)的Er滴度提高了约25%。这项研究可能有助于为进一步评估Er生产系统而做出的不断努力,其目的是在发酵阶段提高Er-A的纯度和产量,并降低工业中的生产成本和环境问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号